Topics

The Sarah Cannon Blood Cancer Network Company Profile

11:10 EST 27th January 2020 | BioPortfolio

Sarah Cannon brings together physician-led blood cancer programs across the United States and United Kingdom to offer patients convenient access to care including blood and marrow transplants and clinical trials. Sarah Cannon Blood Cancer Network programs include St. David’s South Austin Medical Center in Austin, TX, Medical City Dallas Hospital in Dallas, TX, Colorado Blood Cancer Institute at Presbyterian/St. Luke’s Medical Center - HealthONE in Denver, Colo., HCA Midwest Health - Research Medical Center, in Kansas City, Mo., Sarah Cannon Center for Blood Cancer at TriStar Centennial Medical Center in Nashville, Tenn., Tulane Medical Center in New Orleans, La., OU Medical Center in Oklahoma City, Okla., Texas Transplant Institute at Methodist Hospital in San Antonio, TX, Harley Street at University College Hospital in London and The Christie Clinic in Manchester, England. For more information about the Blood Cancer Network and Sarah Cannon’s full suite of oncology services, visit sarahcannon.com.


News Articles [3946 Associated News Articles listed on BioPortfolio]

Daiichi Sankyo initiates clinical trial of DS-7300 in collaboration with Sarah Cannon Research Institute

The study is the first in the strategic oncology partnership announced between Daiichi Sankyo and Sarah Cannon, designed to expedite and optimize global clinical development of Daiichi Sankyo’s The...

Shady Grove Fertility (SGF) Richmond Opens New, State of the Art Fertility Center in Sarah Cannon Building, Henrico Doctors’ Hospital Campus

RICHMOND, Va. (PRWEB) September 11, 2019 SGF Richmond announced today the opening of their brand new fertility center on the cam...

New Cancer Center at Golden Valley Memorial Healthcare Offers Physician Services Provided by Sarah Cannon Cancer Institute at HCA Midwest Health

Golden Valley Memorial Healthcare (GVMH), a leading rural healthcare organization, is proud to announce its new cancer center and partnership with

A Bride Meets the Girl Whose Life She Saved

Sarah Aiken and Kinley Strohl, a young girl who needed Ms. Aiken’s bone marrow, had never met in person. A wedding quickly became an even bigger celebration of new beginnings. SOURCE: DKMS DESCRIPTI...

New Study Finds a Family Risk for Blood Cancer

THURSDAY, Aug. 8, 2019 -- If a close relative has had blood cancer, you're more likely to get it, a large new study reports. The researchers analyzed data from 16 million people in Sweden, including m...

Metabolic effects of an oral blood cancer drug

A recent study found that an effective blood cancer treatment was associated with weight gain, obesity, and increased systolic blood pressure.

Transgender Activist Sarah McBride Is Running For Office

Sarah McBride told reporters it wasn't transgender rights but her late husband's battle with cancer that motivated her to pursue elected office: "I’m running because my experience with Andy undersco...

06.12.12 -- Breakthrough Blood-Based Cancer Gene Testing Technology Launched

06/12/12Laboratory Network.com Newsletter

Drugs and Medications [77 Associated Drugs and Medications listed on BioPortfolio]

Gemcitabine hydrochloride [bluepoint laboratories]

These highlights do not include all the information needed to use Gemcitabine for Injection safely and effectively. See full prescribing information for Gemcitabine for Injection. Gemcitabine for inje...

Gemcitabine [fresenius kabi usa, llc]

These highlights do not include all the information needed to use GEMCITABINE FOR INJECTION, USP safely and effectively. See full prescribing information for GEMCITABINE FOR INJECTION, USP. GEMCITABIN...

Gemcitabine [fresenius kabi usa, llc]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP. Gemcitabin...

Gemcitabine hydrochloride [gland pharma limited]

These highlights do not include all the information needed to use Gemcitabine for Injection, USP safely and effectively. See full prescribing information for Gemcitabine for Injection, USP.Gemcitabine...

Gemcitabine [mylan institutional llc]

These highlights do not include all the information needed to use GEMCITABINE INJECTION safely and effectively. See full prescribing information for GEMCITABINE INJECTION. GEMCITABINE injection, for i...

PubMed Articles [10085 Associated PubMed Articles listed on BioPortfolio]

The association of allogeneic blood transfusion and the recurrence of hepatic cancer after surgical resection.

There is conflicting evidence whether allogeneic blood transfusion influences survival or cancer recurrence after resection of hepatocellular cancer. We followed up 1469 patients who had undergone hep...

Network control principles for identifying personalized driver genes in cancer.

To understand tumor heterogeneity in cancer, personalized driver genes (PDGs) need to be identified for unraveling the genotype-phenotype associations corresponding to particular patients. However, mo...

Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer.

Breast cancer is one of the most common malignancies among females, and its prognosis is affected by a complex network of gene interactions. Weighted gene co-expression network analysis was used to co...

Sarah Costantino PhD FESC.

Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications.

National Cancer Institute Clinical Trial Network (NCTN) groups serve a vital role in identifying effective new antineoplastic regimens. However, the downstream clinical effect of their trials has not ...

Clinical Trials [18616 Associated Clinical Trials listed on BioPortfolio]

SCRI TISSUE TESTING REGISTRY

Sarah Cannon Research Institute (SCRI) is committed to improvement and excellence in clinical research and correlative science. To this end, the SCRI Oncology Research Consortium will coll...

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

In this study, patients with metastatic HER2-negative breast cancer will receive treatment with ixabepilone and sorafenib until disease progression or unacceptable toxicity occurs. The Pha...

Evaluation of the Adhesion to the GENEPY Network

In order to best meet the needs of all those affected by the genetic risk of cancer in our region, it is important to identify the factors likely to influence the course leading to the GEN...

Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)

GENOA, the Genetic Epidemiology Network of Arteriopathy, consists of a network of three field centers and biochemical and genetic core labs to study the common polymorphic genetic variatio...

Family Blood Pressure Program - GenNet Network

To identify new genetic loci regulating blood pressure in hypertensive rats and in case-controls from relevant human populations. The study consists of a four grant network, which in turn...

Companies [2879 Associated Companies listed on BioPortfolio]

Sarah Cannon Blood Cancer Network

The Sarah Cannon Blood Cancer Network is one of the largest providers of blood cancer care including blood and marrow transplantation (BMT) across the United States and United Kin...

The Sarah Cannon Blood Cancer Network

Sarah Cannon brings together physician-led blood cancer programs across the United States and United Kingdom to offer patients convenient access to care including blood and marrow...

Sarah Cannon Research Institute (SCRI)

Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies for patients. It is one of the world’s leading clinical res...

Sarah Cannon Research Institute

Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies for patients. It is one of the largest clinical research program...

The Multiple Myeloma Research Consortium

The Multiple Myeloma Research Consortium (MMRC) is a 509(a)3 non-profit organization that integrates leading academic institutions to accelerate drug development in multiple myelo...

More Information about "The Sarah Cannon Blood Cancer Network" on BioPortfolio

We have published hundreds of The Sarah Cannon Blood Cancer Network news stories on BioPortfolio along with dozens of The Sarah Cannon Blood Cancer Network Clinical Trials and PubMed Articles about The Sarah Cannon Blood Cancer Network for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Sarah Cannon Blood Cancer Network Companies in our database. You can also find out about relevant The Sarah Cannon Blood Cancer Network Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record